E-Learning

Intel (NASDAQ:INTC) Q1 Sales Beat Estimates But Stock Drops

Computer processor maker Intel (NASDAQ:INTC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $12.67 billion. On the other hand, next quarter’s revenue guidance of $11.8 billion was less impressive, coming in 8.4% below analysts’ estimates. Its non-GAAP profit of $0.13 per share was significantly above analysts’ consensus estimates.

Read more

Gilead Sciences (NASDAQ:GILD) Misses Q1 Revenue Estimates

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance of $28.4 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.81 per share was 2.1% above analysts’ consensus estimates.

Read more

Merit Medical Systems (NASDAQ:MMSI) Surprises With Q1 Sales

Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q1 CY2025, with sales up 9.8% year on year to $355.4 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.86 per share was 14.8% above analysts’ consensus estimates.

Read more